Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands |
Total |
Common Stock |
Additional Paid-In Capital |
Accumulated Other Comprehensive (Loss) Income |
Accumulated Deficit |
Treasury Stock |
Common stock, beginning balance (in shares) at Dec. 31, 2021 |
|
70,550,631,000
|
|
|
|
|
Treasury stock, beginning balance (in shares) at Dec. 31, 2021 |
|
|
|
|
|
(16,216,411,000)
|
Beginning balance at Dec. 31, 2021 |
$ 1,291,975
|
$ 71
|
$ 2,334,348
|
$ (1,198)
|
$ (238,760)
|
$ (802,486)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
Unrealized gain (loss) on available-for-sale securities |
(6,547)
|
|
|
(6,547)
|
|
|
Common stock issued under stock incentive plan and ESPP (in shares) |
|
442,646,000
|
|
|
|
|
Common stock issued under stock incentive plan and ESPP |
1,289
|
|
1,289
|
|
|
|
Stock-based compensation expense |
15,510
|
|
15,510
|
|
|
|
Net income (loss) |
(94,774)
|
|
|
|
(94,774)
|
|
Common stock, ending balance (in shares) at Mar. 31, 2022 |
|
70,993,277,000
|
|
|
|
|
Treasury stock, ending balance (in shares) at Mar. 31, 2022 |
|
|
|
|
|
(16,216,411,000)
|
Ending balance at Mar. 31, 2022 |
1,207,453
|
$ 71
|
2,351,147
|
(7,745)
|
(333,534)
|
$ (802,486)
|
Common stock, beginning balance (in shares) at Dec. 31, 2021 |
|
70,550,631,000
|
|
|
|
|
Treasury stock, beginning balance (in shares) at Dec. 31, 2021 |
|
|
|
|
|
(16,216,411,000)
|
Beginning balance at Dec. 31, 2021 |
1,291,975
|
$ 71
|
2,334,348
|
(1,198)
|
(238,760)
|
$ (802,486)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
Net income (loss) |
(186,580)
|
|
|
|
|
|
Common stock, ending balance (in shares) at Jun. 30, 2022 |
|
71,031,792,000
|
|
|
|
|
Treasury stock, ending balance (in shares) at Jun. 30, 2022 |
|
|
|
|
|
(16,216,411,000)
|
Ending balance at Jun. 30, 2022 |
1,124,070
|
$ 71
|
2,362,327
|
(10,502)
|
(425,340)
|
$ (802,486)
|
Common stock, beginning balance (in shares) at Mar. 31, 2022 |
|
70,993,277,000
|
|
|
|
|
Treasury stock, beginning balance (in shares) at Mar. 31, 2022 |
|
|
|
|
|
(16,216,411,000)
|
Beginning balance at Mar. 31, 2022 |
1,207,453
|
$ 71
|
2,351,147
|
(7,745)
|
(333,534)
|
$ (802,486)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
Unrealized gain (loss) on available-for-sale securities |
(2,757)
|
|
|
(2,757)
|
|
|
Common stock issued under stock incentive plan and ESPP (in shares) |
|
38,515,000
|
|
|
|
|
Common stock issued under stock incentive plan and ESPP |
15
|
|
15
|
|
|
|
Stock-based compensation expense |
11,165
|
|
11,165
|
|
|
|
Net income (loss) |
(91,806)
|
|
|
|
(91,806)
|
|
Common stock, ending balance (in shares) at Jun. 30, 2022 |
|
71,031,792,000
|
|
|
|
|
Treasury stock, ending balance (in shares) at Jun. 30, 2022 |
|
|
|
|
|
(16,216,411,000)
|
Ending balance at Jun. 30, 2022 |
$ 1,124,070
|
$ 71
|
2,362,327
|
(10,502)
|
(425,340)
|
$ (802,486)
|
Common stock, beginning balance (in shares) at Dec. 31, 2022 |
55,039,707
|
71,256,118,000
|
|
|
|
|
Treasury stock, beginning balance (in shares) at Dec. 31, 2022 |
(16,216,411)
|
|
|
|
|
(16,216,411,000)
|
Beginning balance at Dec. 31, 2022 |
$ 1,100,814
|
$ 71
|
2,386,325
|
(12,535)
|
(470,561)
|
$ (802,486)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
Unrealized gain (loss) on available-for-sale securities |
4,124
|
|
|
4,124
|
|
|
Common stock issued under stock incentive plan and ESPP (in shares) |
|
501,660,000
|
|
|
|
|
Common stock issued under stock incentive plan and ESPP |
2,467
|
$ 1
|
2,466
|
|
|
|
Stock-based compensation expense |
10,139
|
|
10,139
|
|
|
|
Net income (loss) |
(81,018)
|
|
|
|
(81,018)
|
|
Common stock, ending balance (in shares) at Mar. 31, 2023 |
|
71,757,778,000
|
|
|
|
|
Treasury stock, ending balance (in shares) at Mar. 31, 2023 |
|
|
|
|
|
(16,216,411,000)
|
Ending balance at Mar. 31, 2023 |
$ 1,036,526
|
$ 72
|
2,398,930
|
(8,411)
|
(551,579)
|
$ (802,486)
|
Common stock, beginning balance (in shares) at Dec. 31, 2022 |
55,039,707
|
71,256,118,000
|
|
|
|
|
Treasury stock, beginning balance (in shares) at Dec. 31, 2022 |
(16,216,411)
|
|
|
|
|
(16,216,411,000)
|
Beginning balance at Dec. 31, 2022 |
$ 1,100,814
|
$ 71
|
2,386,325
|
(12,535)
|
(470,561)
|
$ (802,486)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
Common stock issued under stock incentive plan and ESPP (in shares) |
152,849
|
|
|
|
|
|
Net income (loss) |
$ (164,824)
|
|
|
|
|
|
Common stock, ending balance (in shares) at Jun. 30, 2023 |
55,734,775
|
71,951,186,000
|
|
|
|
|
Treasury stock, ending balance (in shares) at Jun. 30, 2023 |
(16,216,411)
|
|
|
|
|
(16,216,411,000)
|
Ending balance at Jun. 30, 2023 |
$ 964,236
|
$ 72
|
2,410,905
|
(8,870)
|
(635,385)
|
$ (802,486)
|
Common stock, beginning balance (in shares) at Mar. 31, 2023 |
|
71,757,778,000
|
|
|
|
|
Treasury stock, beginning balance (in shares) at Mar. 31, 2023 |
|
|
|
|
|
(16,216,411,000)
|
Beginning balance at Mar. 31, 2023 |
1,036,526
|
$ 72
|
2,398,930
|
(8,411)
|
(551,579)
|
$ (802,486)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
Unrealized gain (loss) on available-for-sale securities |
(459)
|
|
|
(459)
|
|
|
Common stock issued under stock incentive plan and ESPP (in shares) |
|
193,408,000
|
|
|
|
|
Common stock issued under stock incentive plan and ESPP |
238
|
|
238
|
|
|
|
Stock-based compensation expense |
11,737
|
|
11,737
|
|
|
|
Net income (loss) |
$ (83,806)
|
|
|
|
(83,806)
|
|
Common stock, ending balance (in shares) at Jun. 30, 2023 |
55,734,775
|
71,951,186,000
|
|
|
|
|
Treasury stock, ending balance (in shares) at Jun. 30, 2023 |
(16,216,411)
|
|
|
|
|
(16,216,411,000)
|
Ending balance at Jun. 30, 2023 |
$ 964,236
|
$ 72
|
$ 2,410,905
|
$ (8,870)
|
$ (635,385)
|
$ (802,486)
|